Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q2 FY25 results · Jul–Sep 2024
Divi's Laboratories reported revenue from operations of ₹2,338.00 crore (up 22.5% from Q2 FY24) and net profit of ₹510.00 crore (up 46.6% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,338.00 | 1,909.00 | +22.5% | 2,118.00 | +10.4% |
| Other income | 106.00 | 86.00 | +23.3% | 79.00 | +34.2% |
| Total income | 2,444.00 | 1,995.00 | +22.5% | 2,197.00 | +11.2% |
| Profit before tax | 722.00 | 469.00 | +53.9% | 604.00 | +19.5% |
| Net profit for the period | 510.00 | 348.00 | +46.6% | 430.00 | +18.6% |
| EPS, basic (₹) | 19.20 | 13.11 | +46.5% | 16.20 | +18.5% |
| Net margin (%) | 21.8 | 18.2 | 20.3 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,302.00 | 1,868.00 | +23.2% | 2,063.00 | +11.6% |
| Other income | 105.00 | 85.00 | +23.5% | 79.00 | +32.9% |
| Total income | 2,407.00 | 1,953.00 | +23.2% | 2,142.00 | +12.4% |
| Profit before tax | 735.00 | 464.00 | +58.4% | 603.00 | +21.9% |
| Net profit for the period | 518.00 | 342.00 | +51.5% | 430.00 | +20.5% |
| EPS, basic (₹) | 19.51 | 12.89 | +51.4% | 16.18 | +20.6% |
| Net margin (%) | 22.5 | 18.3 | 20.8 |
Consolidated
- Filed with BSE
- 09 Nov 2024, 14:25 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2024, 14:25 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE